Pseudohyperaldosteronism type 2
Also known as early-onset hypertension with exacerbation in pregnancy, hypertension due to gain-of-function mutations in the mineralocorticoid receptor, hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, hypertension, early-onset, autosomal dominant, with Severe exacerbation in pregnancy+1 more
early-onset hypertension with exacerbation in pregnancy, hypertension due to gain-of-function mutations in the mineralocorticoid receptor, hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, hypertension, early-onset, autosomal dominant, with Severe exacerbation in pregnancy, hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
early-onset hypertension with exacerbation in pregnancy, hypertension due to gain-of-function mutations in the mineralocorticoid receptor, hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, hypertension, early-onset, autosomal dominant, with Severe exacerbation in pregnancy, hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Related entities are derived from literature co-mention (studied together) — associative, not causal.